Anesthesia, including pain management, critical care (ICU)
Men and women’s health, hormonal drugs
CNS focus psychiatric, epilepsy, Parkinson, CVD
Dermatology
Respiratory focus asthma, COPD, IPF
Oncology, including cancer supportive care
For the abovementioned areas, we are seeking to extend our pipeline and product portfolio by acquiring, in-licensing, or distribution products for the Chinese market:
Innovative pharmaceuticals
Late-stage clinical projects (phase II or III)
Pharmaceuticals with new application forms
Established branded pharmaceuticals